Advances in nutritional therapy in inflammatory bowel diseases: Review

World Journal of Gastroenterology

Volumn 22, Issue 3, 2016, Pages 1045-1066

  Wędrychowicz, Andrzej ^a   Zając, Andrzej ^a   Tomasik, Przemysław ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Dietary factors; Etiology; Exclusive enteral nutrition; Induction therapy; Inflammatory bowel disease; Maintenance therapy; Nutritional therapy; Parenteral nutrition

Indexed keywords

CARBOHYDRATE; TRACE ELEMENT; VITAMIN;

BODY COMPOSITION; BONE MASS; BREAST FEEDING EDUCATION; CENTRAL VENOUS CATHETER; DIET THERAPY; ENTERIC FEEDING; FAT MASS; HUMAN; INFLAMMATORY BOWEL DISEASE; LEAN BODY WEIGHT; LIVER FAILURE; MAINTENANCE THERAPY; MALNUTRITION; METABOLIC DISORDER; NASOGASTRIC TUBE; NAUSEA AND VOMITING; PARENTERAL NUTRITION; PROTEIN INTAKE; QUALITY OF LIFE; REVIEW; VEIN THROMBOSIS; ADVERSE EFFECTS; COLITIS, ULCERATIVE; CROHN DISEASE; DIET; MASS COMMUNICATION; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; RISK FACTOR; TREATMENT OUTCOME; TRENDS;

BODY COMPOSITION; COLITIS, ULCERATIVE; CROHN DISEASE; DIET; DIFFUSION OF INNOVATION; ENTERAL NUTRITION; HUMANS; NUTRITIONAL STATUS; PARENTERAL NUTRITION; RISK FACTORS; TREATMENT OUTCOME;

EID: 84961342109     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i3.1045     Document Type: Review

References (229)

1. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006; 12 Suppl 1: S3-S9 [PMID: 16378007]
2. Goyette P, Labbé C, Trinh TT, Xavier RJ, Rioux JD. Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine. Ann Med 2007; 39: 177-199 [PMID: 17457716]
3. Hartman C, Eliakim R, Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol 2009; 15: 2570-2578 [PMID: 19496185 DOI: 10.3748/wjg.15.2570]
4. O'Sullivan M, O'Morain C. Nutrition in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2006; 20: 561-573 [PMID: 16782529 DOI: 10.1016/j.bpg.2006.03.001]
5. Alastair F, Emma G, Emma P. Nutrition in inflammatory bowel disease. JPEN J Parenter Enteral Nutr 2011; 35: 571-580 [PMID: 21825089 DOI: 10.1177/0148607111413599]
6. Mihai C, Prelipcean CC, Pintilie I, Nedelciuc O, Jigaranu AO, Dranga M, Mihai B. Nutrition in inflammatory bowel diseases. Rev Med Chir Soc Med Nat Iasi 2013; 117: 662-669 [PMID: 24502032]
7. Verma S, Brown S, Kirkwood B, Giaffer MH. Polymeric versus elemental diet as primary treatment in active Crohn's disease: A randomized, double-blind trial. Am J Gastroenterol 2000; 95: 735-739 [PMID: 10710067 DOI: 10.1111/j.1572-0241.2000.01527.x]
8. Gassull MA, Fernández-Bañares F, Cabré E, Papo M, Giaffer MH, Sánchez-Lombraña JL, Richart C, Malchow H, González-Huix F, Esteve M; European Group on Enteral Nutrition in Crohn' s Disease. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 2002; 51: 164-168 [PMID: 12117873 DOI: 10.1136/gut.51.2.164]
9. Carter MJ, Lobo AJ, Travis SP; IBD Section, British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 Suppl 5: V1-V16 [PMID: 15306569 DOI: 10.1136/gut.2004.043372]
10. Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol 2005; 39: S59-S65 [PMID: 15758661]
11. Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010; 25: 325-333 [PMID: 20074146 DOI: 10.1111/j.1440-1746.2009.06140.x]
12. Hlavaty T, Toth J, Koller T, Krajcovicova A, Oravcova S, Zelinkova Z, Huorka M. Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: A Slovak case-control study. United European Gastroenterol J 2013; 1: 109-119 [PMID: 24917948 DOI: 10.1177/2050640613478011]
13. Hansen TS, Jess T, Vind I, Elkjaer M, Nielsen MF, Gamborg M, Munkholm P. Environmental factors in inflammatory bowel disease: A case-control study based on a Danish inception cohort. J Crohns Colitis 2011; 5: 577-584 [PMID: 22115378 DOI: 10.1016/ j.crohns.2011.05.010]
14. Khalili H, Ananthakrishnan AN, Higuchi LM, Richter JM, Fuchs CS, Chan AT. Early life factors and risk of inflammatory bowel disease in adulthood. Inflamm Bowel Dis 2013; 19: 542-547 [PMID: 23429446 DOI: 10.1097/MIB.0b013e31828132f8]
15. Castiglione F, Diaferia M, Morace F, Labianca O, Meucci C, Cuomo A, Panarese A, Romano M, Sorrentini I, D'Onofrio C, Caporaso N, Rispo A. Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": A case-control, multicentre, prospective study in Southern Italy. J Crohns Colitis 2012; 6: 324-329 [PMID: 22405169 DOI: 10.1016/j.crohns.2011.09.003]
16. Barclay AR, Russell RK, Wilson ML, Gilmour WH, Satsangi J, Wilson DC. Systematic review: The role of breastfeeding in the development of pediatric inflammatory bowel disease. J Pediatr 2009; 155: 421-426 [PMID: 19464699 DOI: 10.1016/ j.jpeds.2009.03.017]
17. Klement E, Cohen RV, Boxman J, Joseph A, Reif S. Breastfeeding and risk of inflammatory bowel disease: A systematic review with meta-analysis. Am J Clin Nutr 2004; 80: 1342-1352 [PMID: 15531685]
18. Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Boškoski I, Bruno G, Petito V, Laterza L, Cammarota G, Gaetani E, Sgambato A, Gasbarrini A. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int 2013; 2013: 435268 [PMID: 23991417 DOI: 10.1155/2013/435268]
19. Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 2015; 12: 205-217 [PMID: 25732745 DOI: 10.1038/nrgastro.2015.34]
20. Frolkis A, Dieleman LA, Barkema HW, Panaccione R, Ghosh S, Fedorak RN, Madsen K, Kaplan GG; Alberta IBD Consortium. Environment and the inflammatory bowel diseases. Can J Gastroenterol 2013; 27: e18-e24 [PMID: 23516681]
21. Brock JH. The physiology of lactoferrin. Biochem Cell Biol. 2002; 80: 1-6.
22. birth cohorts. Eur J Gastroenterol Hepatol 2000; 12: 25-30
23. Jakobsen C, Paerregaard A, Munkholm P, Wewer V. Environmental factors and risk of developing paediatric inflammatory bowel disease-A population based study 2007-2009. J Crohns Colitis 2013; 7: 79-88 [PMID: 22748696 DOI: 10.1016/j.crohns.2012.05.024]
24. Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Ragnarsson G, Björnsson E, Bailey Y, O'Morain C, Schwartz D, Odes S, Giannotta M, Girardin G, Kiudelis G, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Martinez-Ares D, Hernandez V, Almer S, Zhulina Y, Halfvarson J, Arebi N, Tsai HH, Sebastian S, Lakatos PL, Langholz E, Munkholm P. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe-an ECCO-EpiCom study. J Crohns Colitis 2014; 8: 607-616 [PMID: 24315795 DOI: 10.1016/j.crohns.2013.11.021]
25. Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997; 40: 754-760 [PMID: 9245929]
26. Bianchi Porro G, Panza E. Smoking, sugar, and inflammatory bowel disease. Br Med J (Clin Res Ed) 1985; 291: 971-972 [PMID: 3929989]
27. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 2013; 145: 970-977 [PMID: 23912083 DOI: 10.1053/j.gastro.2013.07.050]
28. Viladomiu M, Hontecillas R, Yuan L, Lu P, Bassaganya-R iera J. Nutritional protective mechanisms against gut inflammation. J Nutr Biochem 2013; 24: 929-939 [PMID: 23541470 DOI: 10.1016/ j.jnutbio.2013.01.006]
29. Wu GD, Bushmanc FD, Lewis JD. Diet, the human gut microbiota, and IBD. Anaerobe 2013; 24: 117-120 [PMID: 23548695 DOI: 10.1016/j.anaerobe.2013.03.011]
30. Rashid T, Ebringer A, Tiwana H, Fielder M. Role of Klebsiella and collagens in Crohn's disease: A new prospect in the use of lowstarch diet. Eur J Gastroenterol Hepatol 2009; 21: 843-849 [PMID: 19352192 DOI: 10.1097/MEG.0b013e328318ecde]
31. Ebringer A, Rashid T, Tiwana H, Wilson C. A possible link between Crohn's disease and ankylosing spondylitis via Klebsiella infections. Clin Rheumatol 2007; 26: 289-297 [PMID: 16941202 DOI: 10.1007/s10067-006-0391-2]
32. Ebringer A, Wilson C. The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis. Clin Rheumatol 1996; 15 Suppl 1: 62-66 [PMID: 8835506]
33. Suskind DL, Wahbeh G, Gregory N, Vendettuoli H, Christie D. Nutritional therapy in pediatric Crohn disease: The specific carbohydrate diet. J Pediatr Gastroenterol Nutr 2014; 58: 87-91 [PMID: 24048168 DOI: 10.1097/MPG.0000000000000103]
34. Cohen SA, Gold BD, Oliva S, Lewis J, Stallworth A, Koch B, Eshee L, Mason D. Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2014; 59: 516-521 [PMID: 24897165 DOI: 10.1097/MPG.0000000000000449]
35. Gentschew L, Ferguson LR. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res 2012; 56: 524-535 [PMID: 22495981 DOI: 10.1002/ mnfr.201100630]
36. D'Souza S, Levy E, Mack D, Israel D, Lambrette P, Ghadirian P, Deslandres C, Morgan K, Seidman EG, Amre DK. Dietary patterns and risk for Crohn's disease in children. Inflamm Bowel Dis 2008; 14: 367-373 [PMID: 18092347]
37. Bernstein CN. New insights into IBD epidemiology: Are there any lessons for treatment? Dig Dis 2010; 28: 406-410 [PMID: 20926864 DOI: 10.1159/000320394]
38. Ueda Y, Kawakami Y, Kunii D, Okada H, Azuma M, Le DS, Yamamoto S. Elevated concentrations of linoleic acid in erythrocyte membrane phospholipids in patients with inflammatory bowel disease. Nutr Res 2008; 28: 239-244 [PMID: 19083414 DOI: 10.1016/j.nutres.2008.02.005]
39. Tjonneland A, Overvad K, Bergmann MM, Nagel G, Linseisen J, Hallmans G, Palmqvist R, Sjodin H, Hagglund G, Berglund G, Lindgren S, Grip O, Palli D, Day NE, Khaw KT, Bingham S, Riboli E, Kennedy H, Hart A. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: A nested case-control study within a European prospective cohort study. Gut 2009; 58: 1606-1611 [PMID: 19628674 DOI: 10.1136/ gut.2008.169078]
40. Lee JY, Zhao L, Youn HS, Weatherill AR, Tapping R, Feng L, Lee WH, Fitzgerald KA, Hwang DH. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 2004; 279: 16971-16979 [PMID: 14966134]
41. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. Dietary-fatinduced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice. Nature 2012; 487: 104-108 [PMID: 22722865 DOI: 10.1038/nature11225]
42. Kanai T, Matsuoka K, Naganuma M, Hayashi A, Hisamatsu T. Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods. Korean J Intern Med 2014; 29: 409-415 [PMID: 25045286 DOI: 10.3904/kjim.2014.29.4.409]
43. Jantchou P, Morois S, Clavel-Chapelon F, Boutron-R uault MC, Carbonnel F. Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am J Gastroenterol 2010; 105: 2195-2201 [PMID: 20461067 DOI: 10.1038/ajg.2010.192]
44. Spehlmann ME, Begun AZ, Saroglou E, Hinrichs F, Tiemann U, Raedler A, Schreiber S. Risk factors in German twins with inflammatory bowel disease: results of a questionnaire-based survey. J Crohns Colitis 2012; 6: 29-42 [PMID: 22261525 DOI: 10.1016/j.crohns.2011.06.007]
45. Ng SC. Epidemiology of inflammatory bowel disease: focus on Asia. Best Pract Res Clin Gastroenterol 2014; 28: 363-372 [PMID: 24913377 DOI: 10.1016/j.bpg.2014.04.003]
46. Virta LJ, Ashorn M, Kolho KL. Cow's milk allergy, asthma, and pediatric IBD. J Pediatr Gastroenterol Nutr 2013; 56: 649-651 [PMID: 23319082 DOI: 10.1097/MPG.0b013e318285e9d8]
47. Kuenstner JT, Chamberlin W, Naser SA, Collins MT, Dow CT, Aitken JM, Weg S, Telega G, John K, Haas D, Eckstein TM, Kali M, Welch C, Petrie T. Resolution of Crohn's disease and complex regional pain syndrome following treatment of paratuberculosis. World J Gastroenterol 2015; 21: 4048-4062 [PMID: 25852293 DOI: 10.3748/wjg.v21.i13.4048]
48. Bach H. What Role Does Mycobacterium avium subsp. paratuberculosis Play in Crohn's Disease? Curr Infect Dis Rep 2015; 17: 463 [PMID: 25754452 DOI: 10.1007/s11908-015-0463-z]
49. Patel D, Danelishvili L, Yamazaki Y, Alonso M, Paustian ML, Bannantine JP, Meunier-Goddik L, Bermudez LE. The ability of Mycobacterium avium subsp. paratuberculosis to enter bovine epithelial cells is influenced by preexposure to a hyperosmolar environment and intracellular passage in bovine mammary epithelial cells. Infect Immun 2006; 74: 2849-2855 [PMID: 16622223 DOI: 10.1128/IAI.74.5.2849-2855.2006]
50. Nazareth N, Magro F, Machado E, Ribeiro TG, Martinho A, Rodrigues P, Alves R, Macedo GN, Gracio D, Coelho R, Abreu C, Appelberg R, Dias C, Macedo G, Bull T, Sarmento A. Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease. Med Microbiol Immunol 2015; 204: 681-692 [PMID: 25994082]
51. Kaushal N, Kudva AK, Patterson AD, Chiaro C, Kennett MJ, Desai D, Amin S, Carlson BA, Cantorna MT, Prabhu KS. Crucial role of macrophage selenoproteins in experimental colitis. J Immunol 2014; 193: 3683-3692 [PMID: 25187657 DOI: 10.4049/ jimmunol.1400347]
52. MacFarlane AJ, Behan NA, Matias FM, Green J, Caldwell D, Brooks SP. Dietary folate does not significantly affect the intestinal microbiome, inflammation or tumorigenesis in azoxymethanedextran sodium sulphate-treated mice. Br J Nutr 2013; 109: 630-638 [PMID: 23021249 DOI: 10.1017/S0007114512001857]
53. Ooi JH, Li Y, Rogers CJ, Cantorna MT. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfateinduced colitis. J Nutr 2013; 143: 1679-1686 [PMID: 23966330 DOI: 10.3945/jn.113.180794]
54. Meeker S, Seamons A, Paik J, Treuting PM, Brabb T, Grady WM, Maggio-Price L. Increased dietary Vitamin D suppresses MAPK signaling, colitis, and colon cancer. Cancer Res 2014; 74: 4398-4408 [PMID: 24938764 DOI: 10.1158/0008-5472. CAN-13-2820]
55. Ananthakrishnan AN. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2013; 9: 367-374 [PMID: 23935543]
56. Parcell S. Sulfur in human nutrition and applications in medicine. Altern Med Rev 2002; 7: 22-44 [PMID: 11896744]
57. Roediger WE, Duncan A, Kapaniris O, Millard S. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 1993; 104: 802-809 [PMID: 8440437]
58. Martin TD, Chan SS, Hart AR. Environmental factors in the relapse and recurrence of inflammatory bowel disease: A review of the literature. Dig Dis Sci 2015; 60: 1396-1405 [PMID: 25407806]
59. Nickerson KP, Chanin R, McDonald C. Deregulation of intestinal anti-microbial defense by the dietary additive, maltodextrin. Gut Microbes 2015; 6: 78-83 [PMID: 25738413 DOI: 10.1080/194909 76.2015.1005477]
60. Han DY, Fraser AG, Dryland P, Ferguson LR. Environmental factors in the development of chronic inflammation: A case-control study on risk factors for Crohn's disease within New Zealand. Mutat Res 2010; 690: 116-122 [PMID: 19751746 DOI: 10.1016/ j.mrfmmm.2009.09.002]
61. Becker HM, Bertschinger MM, Rogler G. Microparticles and their impact on intestinal immunity. Dig Dis 2012; 30 Suppl 3: 47-54 [PMID: 23295692 DOI: 10.1159/000342602]
62. Butler M, Boyle JJ, Powell JJ, Playford RJ, Ghosh S. Dietary microparticles implicated in Crohn's disease can impair macrophage phagocytic activity and act as adjuvants in the presence of bacterial stimuli. Inflamm Res 2007; 56: 353-361 [PMID: 17878997]
63. Choi HJ, Kim HG, Kim J, Park SH, Park J, Oh CG, Do KH, Lee SJ, Park YC, Ahn SC, Kim YS, Moon Y. Pro-apoptotic action of macrophage inhibitory cytokine 1 and counteraction of activating transcription factor 3 in carrageenan-exposed enterocytes. Toxicol Lett 2014; 231: 1-8 [PMID: 25180886 DOI: 10.1016/ j.toxlet.2014.08.022]
64. Lee IA, Low D, Kamba A, Llado V, Mizoguchi E. Oral caffeine administration ameliorates acute colitis by suppressing chitinase 3-like 1 expression in intestinal epithelial cells. J Gastroenterol 2014; 49: 1206-1216 [PMID: 23925589 DOI: 10.1007/ s00535-013-0865-3]
65. Oz HS, Chen T, de Villiers WJ. Green Tea Polyphenols and Sulfasalazine have Parallel Anti-Inflammatory Properties in Colitis Models. Front Immunol 2013; 4: 132 [PMID: 23761791 DOI: 10.3389/fimmu.2013.00132]
66. Nunes C, Ferreira E, Freitas V, Almeida L, Barbosa RM, Laranjinha J. Intestinal anti-inflammatory activity of red wine extract: unveiling the mechanisms in colonic epithelial cells. Food Funct 2013; 4: 373-383 [PMID: 23233037 DOI: 10.1039/ c2fo30233k]
67. Biasi F, Deiana M, Guina T, Gamba P, Leonarduzzi G, Poli G. Wine consumption and intestinal redox homeostasis. Redox Biol 2014; 2: 795-802 [PMID: 25009781 DOI: 10.1016/ j.redox.2014.06.008]
68. Boehnke KF, Eaton KA, Valdivieso M, Baker LH, Xi C. Animal Model Reveals Potential Waterborne Transmission of Helicobacter pylori Infection. Helicobacter 2015; 20: 326-333 [PMID: 25664781 DOI: 10.1111/hel.12216]
69. Papamichael K, Konstantopoulos P, Mantzaris GJ. Helicobacter pylori infection and inflammatory bowel disease: is there a link? World J Gastroenterol 2014; 20: 6374-6385 [PMID: 24914359 DOI: 10.3748/wjg.v20.i21.6374]
70. Ananthakrishnan AN. Environmental triggers for inflammatory bowel disease. Curr Gastroenterol Rep 2013; 15: 302 [PMID: 23250702 DOI: 10.1007/s11894-012-0302-4]
71. Dotson JL, Kappelman MD, Chisolm DJ, Crandall WV. Racial disparities in readmission, complications, and procedures in children with Crohn's disease. Inflamm Bowel Dis 2015; 21: 801-808 [PMID: 25742396]
72. Sandhu A, Mosli M, Yan B, Wu T, Gregor J, Chande N, Ponich T, Beaton M, Rahman A. Self-Screening for Malnutrition Risk in Outpatient Inflammatory Bowel Disease Patients Using the Malnutrition Universal Screening Tool (MUST). JPEN J Parenter Enteral Nutr 2015; Epub ahead of print [PMID: 25632031]
73. Hengstermann S, Valentini L, Schaper L, Buning C, Koernicke T, Maritschnegg M, Buhner S, Tillinger W, Regano N, Guglielmi F, Winklhofer-Roob BM, Lochs H. Altered status of antioxidant vitamins and fatty acids in patients with inactive inflammatory bowel disease. Clin Nutr 2008; 27: 571-578 [PMID: 18316141 DOI: 10.1016/j.clnu.2008.01.007]
74. Gheorghe C, Pascu O, Iacob R, Vadan R, Iacob S, Goldis A, Tantau M, Dumitru E, Dobru D, Miutescu E, Saftoiu A, Fraticiu A, Tomescu D, Gheorghe L. Nutritional risk screening and prevalence of malnutrition on admission to gastroenterology departments: A multicentric study. Chirurgia (Bucur) 2013; 108: 535-541 [PMID: 23958098]
75. Nguyen GC, Munsell M, Harris ML. Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis 2008; 14: 1105-1111 [PMID: 18302272 DOI: 10.1002/ibd.20429]
76. Mijac DD, Jankovi GL, Jorga J, Krsti MN. Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. Eur J Intern Med 2010; 21: 315-319 [PMID: 20603043 DOI: 10.1016/ j.ejim.2010.04.012]
77. Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 2003; 88: 995-1000 [PMID: 14612366 DOI: 10.1136/adc.88.11.995]
78. Kugathasan S, Nebel J, Skelton JA, Markowitz J, Keljo D, Rosh J, LeLeiko N, Mack D, Griffiths A, Bousvaros A, Evans J, Mezoff A, Moyer S, Oliva-Hemker M, Otley A, Pfefferkorn M, Crandall W, Wyllie R, Hyams J. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr 2007; 151: 523-527 [PMID: 17961699 DOI: 10.1016/j.jpeds.2007.04.004]
79. Flores A, Burstein E, Cipher DJ, Feagins LA. Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease. Dig Dis Sci 2015; 60: 2436-2445 [PMID: 25799938]
80. Dodell GB, Albu JB, Attia L, McGinty J, Pi-Sunyer FX, Laferrere B. The bariatric surgery patient: lost to follow-up; from morbid obesity to severe malnutrition. Endocr Pract 2012; 18: e21-e25 [PMID: 22138075 DOI: 10.4158/EP11200.CR]
81. Pons R, Whitten KE, Woodhead H, Leach ST, Lemberg DA, Day AS. Dietary intakes of children with Crohn's disease. Br J Nutr 2009; 102: 1052-1057 [PMID: 19402936 DOI: 10.1017/ S0007114509359085]
82. Filippi J, Al-Jaouni R, Wiroth JB, Hebuterne X, Schneider SM. Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm Bowel Dis 2006; 12: 185-191 [PMID: 16534419]
83. Azcue M, Rashid M, Griffiths A, Pencharz PB. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut 1997; 41: 203-208 [PMID: 9301499]
84. Toptygina AP, Semikina EL, Bobyleva GV, Miroshkina LV, Petrichuk SV. Cytokine profile in children with inflammatory bowel disease. Biochemistry (Mosc) 2014; 79: 1371-1375 [PMID: 25716731 DOI: 10.1134/S0006297914120116]
85. Gerasimidis K, McGrogan P, Edwards CA. The aetiology and impact of malnutrition in paediatric inflammatory bowel disease. J Hum Nutr Diet 2011; 24: 313-326 [PMID: 21564345 DOI: 10.1111/j.1365-277X.2011.01171.x]
86. Al-Jaouni R, Hebuterne X, Pouget I, Rampal P. Energy metabolism and substrate oxidation in patients with Crohn's disease. Nutrition 2000; 16: 173-178 [PMID: 10705071]
87. Spooren CE, Pierik MJ, Zeegers MP, Feskens EJ, Masclee AA, Jonkers DM. Review article: The association of diet with onset and relapse in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2013; 38: 1172-1187 [PMID: 24118051 DOI: 10.1111/apt.12501]
88. Burnham JM, Shults J, Semeao E, Foster B, Zemel BS, Stallings VA, Leonard MB. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res 2004; 19: 1961-1968 [PMID: 15537438 DOI: 10.1359/jbmr.040908]
89. Vitek L. Bile acid malabsorption in inflammatory bowel disease. Inflamm Bowel Dis 2015; 21: 476-483 [PMID: 25248001 DOI: 10.1097/MIB.0000000000000193]
90. Winter TA, O'keefe SJ, Callanan M, Marks T. Impaired gastric acid and pancreatic enzyme secretion in patients with Crohn's disease may be a consequenece of a poor nutritional state. Inflamm Bowel Dis 2004; 10: 618-625 [PMID: 15472524]
91. Lee SH. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intest Res 2015; 13: 11-18 [PMID: 25691839 DOI: 10.5217/ir.2015.13.1.11]
92. Vasseur F, Gower-R ousseau C, Vernier-Massouille G, Dupas JL, Merle V, Merlin B, Lerebours E, Savoye G, Salomez JL, Cortot A, Colombel JF, Turck D. Nutritional status and growth in pediatric Crohn's disease: A population-based study. Am J Gastroenterol 2010; 105: 1893-1900 [PMID: 20145606 DOI: 10.1038/ ajg.2010.20]
93. Bryant RV, Ooi S, Schultz CG, Goess C, Grafton R, Hughes J, Lim A, Bartholomeusz FD, Andrews JM. Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther 2015; 41: 895-906 [PMID: 25753216 DOI: 10.1111/apt.13156]
94. Bryant RV, Trott MJ, Bartholomeusz FD, Andrews JM. Systematic review: body composition in adults with inflammatory bowel disease. Aliment Pharmacol Ther 2013; 38: 213-225 [PMID: 23763279 DOI: 10.1111/apt.12372]
95. Hill RJ. Update on nutritional status, body composition and growth in paediatric inflammatory bowel disease. World J Gastroenterol 2014; 20: 3191-3197 [PMID: 24696604 DOI: 10.3748/wjg.v20. i12.3191]
96. Werkstetter KJ, Ullrich J, Schatz SB, Prell C, Koletzko B, Koletzko S. Lean body mass, physical activity and quality of life in paediatric patients with inflammatory bowel disease and in healthy controls. J Crohns Colitis 2012; 6: 665-673 [PMID: 22398103 DOI: 10.1016/j.crohns.2011.11.017]
97. Wiskin AE, Wootton SA, Hunt TM, Cornelius VR, Afzal NA, Jackson AA, Beattie RM. Body composition in childhood inflammatory bowel disease. Clin Nutr 2011; 30: 112-115 [PMID: 20728967 DOI: 10.1016/j.clnu.2010.07.014]
98. Burnham JM, Shults J, Semeao E, Foster BJ, Zemel BS, Stallings VA, Leonard MB. Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr 2005; 82: 413-420 [PMID: 16087987]
99. Thayu M, Shults J, Burnham JM, Zemel BS, Baldassano RN, Leonard MB. Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease. Inflamm Bowel Dis 2007; 13: 1121-1128 [PMID: 17427245]
100. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Body composition in patients with inflammatory bowel disease: A population-based study. Am J Gastroenterol 2003; 98: 1556-1562 [PMID: 12873577]
101. Katznelson L, Fairfield WP, Zeizafoun N, Sands BE, Peppercorn MA, Rosenthal DI, Klibanski A. Effects of growth hormone secretion on body composition in patients with Crohn's disease. J Clin Endocrinol Metab 2003; 88: 5468-5472 [PMID: 14602791 DOI: 10.1210/jc.2003-030608]
102. Zaltman C, Braulio VB, Outeiral R, Nunes T, de Castro CL. Lower extremity mobility limitation and impaired muscle function in women with ulcerative colitis. J Crohns Colitis 2014; 8: 529-535 [PMID: 24315794 DOI: 10.1016/j.crohns.2013.11.006]
103. Sentongo TA, Semeao EJ, Piccoli DA, Stallings VA, Zemel BS. Growth, body composition, and nutritional status in children and adolescents with Crohn's disease. J Pediatr Gastroenterol Nutr 2000; 31: 33-40 [PMID: 10896068]
104. Dung NQ, Fusch G, Armbrust S, Jochum F, Fusch C. Use of bioelectrical impedance analysis and anthropometry to measure fat-free mass in children and adolescents with Crohn disease. J Pediatr Gastroenterol Nutr 2007; 44: 130-135 [PMID: 17204966]
105. Fink C, Karagiannides I, Bakirtzi K, Pothoulakis C. Adipose tissue and inflammatory bowel disease pathogenesis. Inflamm Bowel Dis 2012; 18: 1550-1557 [PMID: 22407798 DOI: 10.1002/ibd.22893]
106. Weakley FL, Turnbull RB. Recognition of regional ileitis in the operating room. Dis Colon Rectum 1971; 14: 17-23 [PMID: 5552686]
107. Sheehan AL, Warren BF, Gear MW, Shepherd NA. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg 1992; 79: 955-958 [PMID: 1422768]
108. Ponemone V, Keshavarzian A, Brand MI, Saclarides T, Abcarian H, Cabay RJ, Fletcher E, Larsen B, Durstine LJ, Fantuzzi G, Fayad R. Apoptosis and inflammation: role of adipokines in inflammatory bowel disease. Clin Transl Gastroenterol 2010; 1: e1 [PMID: 23238652 DOI: 10.1038/ctg.2010.1]
109. Lim H, Kim HJ, Hong SJ, Kim S. Nutrient intake and bone mineral density by nutritional status in patients with inflammatory bowel disease. J Bone Metab 2014; 21: 195-203 [PMID: 25247157 DOI: 10.11005/jbm.2014.21.3.195]
110. Dumitrescu G, Mihai C, Dranga M, Prelipcean CC. Bone mineral density in patients with inflammatory bowel disease from northeastern Romania. Rev Med Chir Soc Med Nat Iasi 2013; 117: 23-28 [PMID: 24505888]
111. Miznerova E, Hlavaty T, Koller T, Toth J, Holociova K, Huorka M, Killinger Z, Payer J. The prevalence and risk factors for osteoporosis in patients with inflammatory bowel disease. Bratisl Lek Listy 2013; 114: 439-445 [PMID: 23944617]
112. Kim HJ, Hong SJ, Jeon YW, Han JP, Han SH, Kang JH, Tae JW, Lim HS, Kim HK, Ko BM, Lee MS. The early onset of disease may be a risk factor for decreased bone mineral density in patients with inflammatory bowel disease. Clin Endosc 2013; 46: 71-76 [PMID: 23423611 DOI: 10.5946/ce.2013.46.1.71]
113. Miheller P, Gesztes W, Lakatos PL. Manipulating bone disease in inflammatory bowel disease patients. Ann Gastroenterol 2013; 26: 296-303 [PMID: 24714303]
114. Adriani A, Pantaleoni S, Luchino M, Ribaldone DG, Reggiani S, Sapone N, Sguazzini C, Isaia G, Pellicano R, Astegiano M. Osteopenia and osteoporosis in patients with new diagnosis of inflammatory bowel disease. Panminerva Med 2014; 56: 145-149 [PMID: 24994578]
115. Abraham BP, Prasad P, Malaty HM. Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients. Dig Dis Sci 2014; 59: 1878-1884 [PMID: 24619280 DOI: 10.1007/s10620-014-3102-x]
116. Gupta S, Wu X, Moore T, Shen B. Frequency, risk factors, and adverse sequelae of bone loss in patients with ostomy for inflammatory bowel diseases. Inflamm Bowel Dis 2014; 20: 259-264 [PMID: 24378598 DOI: 10.1097/01.MIB.0000439065.92211.d3]
117. Targownik LE, Bernstein CN, Nugent Z, Johansson H, Oden A, McCloskey E, Kanis JA, Leslie WD. Inflammatory bowel disease and the risk of fracture after controlling for FRAX. J Bone Miner Res 2013; 28: 1007-1013 [PMID: 23239264 DOI: 10.1002/ jbmr.1848]
118. Targownik LE, Bernstein CN, Nugent Z, Leslie WD. Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis. Clin Gastroenterol Hepatol 2013; 11: 278-285 [PMID: 23103821 DOI: 10.1016/j.cgh.2012.10.022]
119. Wong SC, Catto-Smith AG, Zacharin M. Pathological fractures in paediatric patients with inflammatory bowel disease. Eur J Pediatr 2014; 173: 141-151 [PMID: 24132387 DOI: 10.1007/ s00431-013-2174-5]
120. Schmidt S, Mellström D, Norjavaara E, Sundh V, Saalman R. Longitudinal assessment of bone mineral density in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2012; 55: 511-518 [PMID: 22688562 DOI: 10.1097/MPG.0b013e31825817a0]
121. Targownik LE, Bernstein CN, Leslie WD. Risk factors and management of osteoporosis in inflammatory bowel disease. Curr Opin Gastroenterol 2014; 30: 168-174 [PMID: 24419292 DOI: 10.1097/MOG.0000000000000037]
122. Pichler J, Hanslik A, Huber WD, Aufricht C, Bidmon-Fliegenschnee B. Paediatric patients with inflammatory bowel disease who received infliximab experienced improved growth and bone health. Acta Paediatr 2014; 103: e69-e75 [PMID: 24237381 DOI: 10.1111/apa.12448]
123. van Sommeren S, Janse M, Karjalainen J, Fehrmann R, Franke L, Fu J, Weersma RK. Extraintestinal manifestations and complications in inflammatory bowel disease: from shared genetics to shared biological pathways. Inflamm Bowel Dis 2014; 20: 987-994 [PMID: 24739630 DOI: 10.1097/ MIB.0000000000000032]
124. Billiet T, Vermeire S. Differences between adults and children: genetics and beyond. Expert Rev Gastroenterol Hepatol 2015; 9: 191-196 [PMID: 25134842 DOI: 10.1586/17474124.2014.950228]
125. Terzoudis S, Zavos C, Koutroubakis IE. The bone and fat connection in inflammatory bowel diseases. Inflamm Bowel Dis 2014; 20: 2207-2217 [PMID: 24983981 DOI: 10.1097/ MIB.0000000000000111]
126. Veit LE, Maranda L, Fong J, Nwosu BU. The Vitamin D status in inflammatory bowel disease. PLoS One 2014; 9: e101583 [PMID: 24992465 DOI: 10.1371/journal.pone.0101583]
127. Kini GP, Young B, Herbison P, Schultz M. Does seasonal level of serum 25-OH Vitamin D correlate with the activity of Crohn's disease? N Z Med J 2014; 127: 51-59 [PMID: 24929571]
128. Dumitrescu G, Mihai C, Dranga M, Prelipcean CC. Serum 25-hydroxyVitamin D concentration and inflammatory bowel disease characteristics in Romania. World J Gastroenterol 2014; 20: 2392-2396 [PMID: 24605037 DOI: 10.3748/wjg.v20.i9.2392]
129. Tan B, Li P, Lv H, Li Y, Wang O, Xing XP, Qian JM. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease. J Dig Dis 2014; 15: 116-123 [PMID: 24354597 DOI: 10.1111/1751-2980.12118]
130. Mouli VP, Ananthakrishnan AN. Review article: Vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther 2014; 39: 125-136 [PMID: 24236989 DOI: 10.1111/apt.12553]
131. Garg M, Rosella O, Lubel JS, Gibson PR. Association of circulating Vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 2634-2643 [PMID: 24105392 DOI: 10.1097/01.MIB.0000436957.77533.b2]
132. Hlavaty T, Krajcovicova A, Koller T, Toth J, Nevidanska M, Huorka M, Payer J. Higher Vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases. World J Gastroenterol 2014; 20: 15787-15796 [PMID: 25400464 DOI: 10.3748/wjg.v20.i42.15787]
133. Rogler G, Vavricka S. Anemia in inflammatory bowel disease: an under-estimated problem? Front Med (Lausanne) 2014; 1: 58[PMID: 25646159 DOI: 10.3389/fmed.2014.00058]
134. Filmann N, Rey J, Schneeweiss S, Ardizzone S, Bager P, Bergamaschi G, Koutroubakis I, Lindgren S, Morena Fde L, Moum B, Vavricka SR, Schröder O, Herrmann E, Blumenstein I. Prevalence of anemia in inflammatory bowel diseases in european countries: A systematic review and individual patient data metaanalysis. Inflamm Bowel Dis 2014; 20: 936-945 [PMID: 24572205 DOI: 10.1097/01.MIB.0000442728.74340.fd]
135. Goldenberg BA, Graff LA, Clara I, Zarychanski R, Walker JR, Carr R, Rogala L, Miller N, Bernstein CN. Is iron deficiency in the absence of anemia associated with fatigue in inflammatory bowel disease? Am J Gastroenterol 2013; 108: 1392-1397 [PMID: 24005345 DOI: 10.1038/ajg.2013.14]
136. Sikora SK, Spady D, Prosser C, El-Matary W. Trace elements and vitamins at diagnosis in pediatric-onset inflammatory bowel disease. Clin Pediatr (Phila) 2011; 50: 488-492 [PMID: 21317196 DOI: 10.1177/0009922810397041]
137. Alkhouri RH, Hashmi H, Baker RD, Gelfond D, Baker SS. Vitamin and mineral status in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013; 56: 89-92 [PMID: 22832510 DOI: 10.1097/MPG.0b013e31826a105d]
138. Ringstad J, Kildebo S, Thomassen Y. Serum selenium, copper, and zinc concentrations in Crohn's disease and ulcerative colitis. Scand J Gastroenterol 1993; 28: 605-608 [PMID: 8362213]
139. Geerling BJ, Badart-Smook A, Stockbrügger RW, Brummer RJ. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr 2000; 54: 514-521 [PMID: 10878655]
140. Ojuawo A, Keith L. The serum concentrations of zinc, copper and selenium in children with inflammatory bowel disease. Cent Afr J Med 2002; 48: 116-119 [PMID: 14562534]
141. Antunes CV, Hallack Neto AE, Nascimento CR, Chebli LA, Moutinho IL, Pinheiro Bdo V, Reboredo MM, Malaguti C, Castro AC, Chebli JM. Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology. Biomed Res Int 2015; 2015: 728925 [PMID: 25705682 DOI: 10.1155/2015/728925]
142. Battat R, Kopylov U, Szilagyi A, Saxena A, Rosenblatt DS, Warner M, Bessissow T, Seidman E, Bitton A. Vitamin B12 deficiency in inflammatory bowel disease: prevalence, risk factors, evaluation, and management. Inflamm Bowel Dis 2014; 20: 1120-1128 [PMID: 24739632 DOI: 10.1097/MIB.0000000000000024]
143. Yakut M, Ustün Y, Kabaçam G, Soykan I. Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. Eur J Intern Med 2010; 21: 320-323 [PMID: 20603044 DOI: 10.1016/ j.ejim.2010.05.007]
144. Nowak JK, Grzybowska-Chlebowczyk U, Landowski P, Szaflarska-Poplawska A, Klincewicz B, Adamczak D, Banasiewicz T, Plawski A, Walkowiak J. Prevalence and correlates of vitamin K deficiency in children with inflammatory bowel disease. Sci Rep 2014; 4: 4768 [PMID: 24759680 DOI: 10.1038/srep04768]
145. Vagianos K, Bernstein CN. Homocysteinemia and B vitamin status among adult patients with inflammatory bowel disease: A one-year prospective follow-up study. Inflamm Bowel Dis 2012; 18: 718-724 [PMID: 21604334 DOI: 10.1002/ibd.21785]
146. Prince AC, Moosa A, Lomer MC, Reidlinger DP, Whelan K. Variable access to quality nutrition information regarding inflammatory bowel disease: A survey of patients and health professionals and objective examination of written information. Health Expect 2014; Epub ahead of print [PMID: 24934409 DOI: 10.1111/hex.12219]
147. Semrad CE. Use of parenteral nutrition in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2012; 8: 393-395 [PMID: 22933876]
148. Guagnozzi D, González-Castillo S, Olveira A, Lucendo AJ. Nutritional treatment in inflammatory bowel disease. An update. Rev Esp Enferm Dig 2012; 104: 479-488 [PMID: 23130856]
149. Sandhu BK, Fell JM, Beattie RM, Mitton SG, Wilson DC, Jenkins H; IBD Working Group of the British Society of Paediatric Gastroenterology, Hepatology, and Nutrition. Guidelines for the management of inflammatory bowel disease in children in the United Kingdom. J Pediatr Gastroenterol Nutr 2010; 50 Suppl 1: S1-S13 [PMID: 20081543 DOI: 10.1097/ MPG.0b013e3181c92c53]
150. Papi C, Fascì-Spurio F, Rogai F, Settesoldi A, Margagnoni G, Annese V. Mucosal healing in inflammatory bowel disease: treatment efficacy and predictive factors. Dig Liver Dis 2013; 45: 978-985 [PMID: 24018244 DOI: 10.1016/j.dld.2013.07.006]
151. Markel TA, Lou DC, Pfefferkorn M, Scherer LR, West K, Rouse T, Engum S, Ladd A, Rescorla FJ, Billmire DF. Steroids and poor nutrition are associated with infectious wound complications in children undergoing first stage procedures for ulcerative colitis. Surgery 2008; 144: 540-545; discussion 545-547 [PMID: 18847637 DOI: 10.1016/j.surg.2008.07.005]
152. Tighe MP, Cummings JR, Afzal NA. Nutrition and inflammatory bowel disease: primary or adjuvant therapy. Curr Opin Clin Nutr Metab Care 2011; 14: 491-496 [PMID: 21832904 DOI: 10.1097/ MCO.0b013e328349eb4d]
153. Wild GE, Drozdowski L, Tartaglia C, Clandinin MT, Thomson AB. Nutritional modulation of the inflammatory response in inflammatory bowel disease-from the molecular to the integrative to the clinical. World J Gastroenterol 2007; 13: 1-7 [PMID: 17206749 DOI: 10.3748/wjg.v13.i1.1]
154. Scolapio JS. The role of total parenteral nutrition in the management of patients with acute attacks of inflammatory bowel disease. J Clin Gastroenterol 1999; 29: 223-224 [PMID: 10509948]
155. McIntyre PB, Ritchie JK, Hawley PR, Bartram CI, Lennard-Jones JE. Management of enterocutaneous fistulas: A review of 132 cases. Br J Surg 1984; 71: 293-296 [PMID: 6423028]
156. Ostro MJ, Greenberg GR, Jeejeebhoy KN. Total parenteral nutrition and complete bowel rest in the management of Crohn's disease. JPEN J Parenter Enteral Nutr 1985; 9: 280-287 [PMID: 3925172]
157. de Luis DA, Culebras JM, Aller R, Eiros-Bouza JM. Surgical infection and malnutrition. Nutr Hosp 2014; 30: 509-513 [PMID: 25238824 DOI: 10.3305/nh.2014.30.3.7702]
158. Ridley E, Gantner D, Pellegrino V. Nutrition therapy in critically ill patients-A review of current evidence for clinicians. Clin Nutr 2015; 34: 565-571 [PMID: 25616601 DOI: 10.1016/ j.clnu.2014.12.008]
159. Koretz RL, Avenell A, Lipman TO, Braunschweig CL, Milne AC. Does enteral nutrition affect clinical outcome? A systematic review of the randomized trials. Am J Gastroenterol 2007; 102: 412-29; quiz 468 [PMID: 17311654]
160. Fevang BT, Fevang J, Lie SA, Søreide O, Svanes K, Viste A. Long-term prognosis after operation for adhesive small bowel obstruction. Ann Surg 2004; 240: 193-201 [PMID: 15273540]
161. Triantafillidis JK, Vagianos C, Papalois AE. The role of enteral nutrition in patients with inflammatory bowel disease: current aspects. Biomed Res Int 2015; 2015: 197167 [PMID: 25793189 DOI: 10.1155/2015/197167]
162. Wagner IJ, Rombeau JL. Nutritional support of surgical patients with inflammatory bowel disease. Surg Clin North Am 2011; 91: 787-803, viii [PMID: 21787968 DOI: 10.1016/j.suc.2011.04.013]
163. Diamanti A, Bizzarri C, Basso MS, Gambarara M, Cappa M, Daniele A, Noto C, Castro M. How does long-term parenteral nutrition impact the bone mineral status of children with intestinal failure? J Bone Miner Metab 2010; 28: 351-358 [PMID: 20033239 DOI: 10.1007/s00774-009-0140-0]
164. Hernandez C, Simo R, Chacon P, Sabin P, Baena JA, Castellanos JM, Planas M. Influence of surgical stress and parenteral nutrition on serum leptin concentration. Clin Nutr 2000; 19: 61-64 [PMID: 10700536]
165. Dudley J, Rogers R, Sealy L. Renal consequences of parenteral nutrition. Pediatr Nephrol 2014; 29: 375-385 [PMID: 23624823 DOI: 10.1007/s00467-013-2469-9]
166. Blackmer AB, Warschausky S, Siddiqui S, Welch KB, Horn K, Wester A, Warschausky M, Teitelbaum DH. Preliminary findings of long-term neurodevelopmental outcomes of infants treated with intravenous fat emulsion reduction for the management of parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 2015; 39: 34-46 [PMID: 25293944 DOI: 10.1177/014 8607114551965]
167. Lawi.ski M, Jachnis A, Ukleja A, Pertkiewicz M. Cholelithiasis in home parenteral nutrition (Hpn) patients-complications of the clinical nutrition: diagnosis, treatment, prevention. Pol Przegl Chir 2014; 86: 111-115 [PMID: 24791812 DOI: 10.2478/pjs-2014-0021]
168. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver 2012; 6: 172-187 [PMID: 22570746 DOI: 10.5009/gnl.2012.6.2.172]
169. Bozzetti F, Mariani L, Bertinet DB, Chiavenna G, Crose N, De Cicco M, Gigli G, Micklewright A, Moreno Villares JM, Orban A, Pertkiewicz M, Pironi L, Vilas MP, Prins F, Thul P. Central venous catheter complications in 447 patients on home parenteral nutrition: an analysis of over 100.000 catheter days. Clin Nutr 2002; 21: 475-485 [PMID: 12468367]
170. Crispin A, Thul P, Arnold D, Schild S, Weimann A. Central venous catheter complications during home parenteral nutrition: A prospective pilot study of 481 patients with more than 30,000 catheter days. Onkologie 2008; 31: 605-609 [PMID: 19145093 DOI: 10.1159/000162286]
171. Higuera I, Garcia-Peris P, Camblor M, Breton I, Velasco C, Romero R, Frias L, Cuerda C. Outcomes of a general hospitalbased home parenteral nutrition (HPN) program; report of our experience from a 26-year period. Nutr Hosp 2014; 30: 359-365 [PMID: 25208791 DOI: 10.3305/nh.2014.30.2.7592]
172. Crowley JJ. Vascular access. Tech Vasc Interv Radiol 2003; 6: 176-181 [PMID: 14767849]
173. Wall CL, Day AS, Gearry RB. Use of exclusive enteral nutrition in adults with Crohn's disease: A review. World J Gastroenterol 2013; 19: 7652-7660 [PMID: 24282355 DOI: 10.3748/wjg.v19.i43.7652]
174. Whitten KE, Rogers P, Ooi CY, Day AS. International survey of enteral nutrition protocols used in children with Crohn's disease. J Dig Dis 2012; 13: 107-112 [PMID: 22257479 DOI: 10.1111/ j.1751-2980.2011.00558.x]
175. Brown B, Roehl K, Betz M. Enteral nutrition formula selection: current evidence and implications for practice. Nutr Clin Pract 2015; 30: 72-85 [PMID: 25516537 DOI: 10.1177/0884533614561 791]
176. Heuschkel RB. Enteral nutrition in children with Crohn's disease. J Pediatr Gastroenterol Nutr 2000; 31: 575 [PMID: 11144448]
177. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn'es disease. Cochrane Database Syst Rev 2007; Epub ahead of print [PMID: 17253452]
178. Fell JM, Paintin M, Arnaud-Battandier F, Beattie RM, Hollis A, Kitching P, Donnet-Hughes A, MacDonald TT, Walker-Smith JA. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 2000; 14: 281-289 [PMID: 10735920]
179. Griga T, Voigt E, Gretzer B, Brasch F, May B. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 1999; 46: 920-923 [PMID: 10370639]
180. Fell JM. Control of systemic and local inflammation with transforming growth factor beta containing formulas. JPEN J Parenter Enteral Nutr 2005; 29: S126-S128; discussion S129-S133, S184-188 [PMID: 15980274]
181. Bannerjee K, Camacho-Hubner C, Babinska K, Dryhurst KM, Edwards R, Savage MO, Sanderson IR, Croft NM. Antiinflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 2004; 38: 270-275 [PMID: 15076624]
182. Hartman C, Berkowitz D, Weiss B, Shaoul R, Levine A, Adiv OE, Shapira R, Fradkin A, Wilschanski M, Tamir A, Shamir R. Nutritional supplementation with polymeric diet enriched with transforming growth factor-beta 2 for children with Crohn's disease. Isr Med Assoc J 2008; 10: 503-507 [PMID: 18751627]
183. Wedrychowicz A, Kowalska-Duplaga K, Jedynak-Wasowicz U, Pieczarkowski S, Sladek M, Tomasik P, Fyderek K. Serum concentrations of VEGF and TGF1 during exclusive enteral nutrition in IBD. J Pediatr Gastroenterol Nutr 2011; 53: 150-155 [PMID: 21788755 DOI: 10.1097/MPG.0b013e3182144c74]
184. Wedrychowicz A, Kowalska-Duplaga K, Pieczarkowski S, Tomasik P, Spodaryk M, Fyderek K. [Influence of enteral nutrition therapy on serum angiogenic growth factors concentrations in children]. Przegl Lek 2010; 67: 31-35 [PMID: 20509569]
185. Alhagamhmad MH, Day AS, Lemberg DA, Leach ST. An update of the role of nutritional therapy in the management of Crohn's disease. J Gastroenterol 2012; 47: 872-882 [PMID: 22699323 DOI: 10.1007/s00535-012-0617-9]
186. Lecleire S, Hassan A, Marion-Letellier R, Antonietti M, Savoye G, Bole-Feysot C, Lerebours E, Ducrotte P, Dechelotte P, Coeffier M. Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in association with changes in nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways. J Nutr 2008; 138: 2481-2486 [PMID: 19022976 DOI: 10.3945/jn.108.099127]
187. Coeffier M, Marion-Letellier R, Dechelotte P. Potential for amino acids supplementation during inflammatory bowel diseases. Inflamm Bowel Dis 2010; 16: 518-524 [PMID: 19572337 DOI: 10.1002/ibd.21017]
188. Montejo JC, Zarazaga A, Lopez-Martinez J, Urrutia G, Roque M, Blesa AL, Celaya S, Conejero R, Galban C, Garcia de Lorenzo A, Grau T, Mesejo A, Ortiz-Leyba C, Planas M, Ordonez J, Jimenez FJ. Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin Nutr 2003; 22: 221-233 [PMID: 12765660 DOI: 10.1016/S0261-5614(03)00007-4]
189. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: A systematic review and analysis of the literature. Intensive Care Med 2008; 34: 1980-1990 [PMID: 18626628 DOI: 10.1007/ s00134-008-1213-6]
190. Akobeng AK, Miller V, Stanton J, Elbadri AM, Thomas AG. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 2000; 30: 78-84 [PMID: 10630444]
191. Kreymann KG, Berger MM, Deutz NE, Hiesmayr M, Jolliet P, Kazandjiev G, Nitenberg G, van den Berghe G, Wernerman J, Ebner C, Hartl W, Heymann C, Spies C. ESPEN Guidelines on Enteral Nutrition: Intensive care. Clin Nutr 2006; 25: 210-223 [PMID: 16697087 DOI: 10.1016/j.clnu.2006.01.021]
192. Gerasimidis K, Bertz M, Hanske L, Junick J, Biskou O, Aguilera M, Garrick V, Russell RK, Blaut M, McGrogan P, Edwards CA. Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition. Inflamm Bowel Dis 2014; 20: 861-871 [PMID: 24651582 DOI: 10.1097/ MIB.0000000000000023]
193. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-108 [PMID: 21885731 DOI: 10.1126/science.1208344]
194. Leach ST, Mitchell HM, Eng WR, Zhang L, Day AS. Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn's disease. Aliment Pharmacol Ther 2008; 28: 724-733 [PMID: 19145728]
195. Lionetti P, Callegari ML, Ferrari S, Cavicchi MC, Pozzi E, de Martino M, Morelli L. Enteral nutrition and microflora in pediatric Crohn's disease. JPEN J Parenter Enteral Nutr 2005; 29: S173-S175; discussion S175-S178, S184-S188 [PMID: 15980280 DOI: 10.1177/01486071050290S4S173]
196. Lochs H, Dejong C, Hammarqvist F, Hebuterne X, Leon-Sanz M, Schütz T, van Gemert W, van Gossum A, Valentini L, Lübke H, Bischoff S, Engelmann N, Thul P. ESPEN Guidelines on Enteral Nutrition: Gastroenterology. Clin Nutr 2006; 25: 260-274 [PMID: 16698129]
197. Akobeng AK. Crohn's disease: current treatment options. Arch Dis Child 2008; 93: 787-792 [PMID: 18456695 DOI: 10.1136/ adc.2007.128751]
198. Day AS, Whitten KE, Sidler M, Lemberg DA. Systematic review: nutritional therapy in paediatric Crohn's disease. Aliment Pharmacol Ther 2008; 27: 293-307 [PMID: 18045244]
199. Stewart M, Day AS, Otley A. Physician attitudes and practices of enteral nutrition as primary treatment of paediatric Crohn disease in North America. J Pediatr Gastroenterol Nutr 2011; 52: 38-42 [PMID: 20975582 DOI: 10.1097/MPG.0b013e3181e2c724]
200. Wong S, Lemberg DA, Day AS. Exclusive enteral nutrition in the management of perianal Crohn's disease in children. J Dig Dis 2010; 11: 185-188 [PMID: 20579222 DOI: 10.1111/ j.1751-2980.2010.00434.x]
201. Johnson T, Macdonald S, Hill SM, Thomas A, Murphy MS. Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: A randomised controlled trial. Gut 2006; 55: 356-361 [PMID: 16162683]
202. Rubio A, Pigneur B, Garnier-Lengliné H, Talbotec C, Schmitz J, Canioni D, Goulet O, Ruemmele FM. The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding. Aliment Pharmacol Ther 2011; 33: 1332-1339 [PMID: 21507029 DOI: 10.1111/j.1365-2036.2011.04662.x]
203. Kappelman MD, Bousvaros A. Nutritional concerns in pediatric inflammatory bowel disease patients. Mol Nutr Food Res 2008; 52: 867-874 [PMID: 18324705 DOI: 10.1002/mnfr.200700156]
204. Dignass A, Van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF, Danese S, D'Hoore A, Gassull M, Gomollón F, Hommes DW, Michetti P, O'Morain C, Oresland T, Windsor A, Stange EF, Travis SP. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis 2010; 4: 28-62 [PMID: 21122489 DOI: 10.1016/j.crohns.2009.12.002]
205. Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol 2009; 104: 465-483; quiz 464, 484 [PMID: 19174807 DOI: 10.1038/ ajg.2008.168]
206. Matsui T, Sakurai T, Yao T. Nutritional therapy for Crohn's disease in Japan. J Gastroenterol 2005; 40 Suppl 16: 25-31 [PMID: 15902960]
207. Day AS, Whitten KE, Lemberg DA, Clarkson C, Vitug-Sales M, Jackson R, Bohane TD. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: A feasible and effective approach. J Gastroenterol Hepatol 2006; 21: 1609-1614 [PMID: 16928225]
208. Frivolt K, Schwerd T, Werkstetter KJ, Schwarzer A, Schatz SB, Bufler P, Koletzko S. Repeated exclusive enteral nutrition in the treatment of paediatric Crohn's disease: predictors of efficacy and outcome. Aliment Pharmacol Ther 2014; 39: 1398-1407 [PMID: 24779671 DOI: 10.1111/apt.12770]
209. Panaccione R, Ghosh S. Optimal use of biologics in the management of Crohn's disease. Therap Adv Gastroenterol 2010; 3: 179-189 [PMID: 21180600 DOI: 10.1177/1756283X09357579]
210. Li Y, Zuo L, Zhu W, Gong J, Zhang W, Gu L, Guo Z, Cao L, Li N, Li J. Role of exclusive enteral nutrition in the preoperative optimization of patients with Crohn's disease following immunosuppressive therapy. Medicine (Baltimore) 2015; 94: e478 [PMID: 25654387 DOI: 10.1097/MD.0000000000000478]
211. Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 1996; 38: 543-548 [PMID: 8707085]
212. Duncan H, Buchanan E, Cardigan T, Garrick V, Curtis L, McGrogan P, Barclay A, Russell RK. A retrospective study showing maintenance treatment options for paediatric CD in the first year following diagnosis after induction of remission with EEN: supplemental enteral nutrition is better than nothing! BMC Gastroenterol 2014; 14: 50 [PMID: 24645851 DOI: 10.1186/1471-230X-14-50]
213. Hanai H, Iida T, Takeuchi K, Arai H, Arai O, Abe J, Tanaka T, Maruyama Y, Ikeya K, Sugimoto K, Nakamura T, Nakamura K, Watanabe F. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease. Dig Liver Dis 2012; 44: 649-654 [PMID: 22542605 DOI: 10.1016/ j.dld.2012.03.007]
214. Takagi S, Utsunomiya K, Kuriyama S, Yokoyama H, Takahashi S, Iwabuchi M, Takahashi H, Takahashi S, Kinouchi Y, Hiwatashi N, Funayama Y, Sasaki I, Tsuji I, Shimosegawa T. Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: A randomized-controlled trial. Aliment Pharmacol Ther 2006; 24: 1333-1340 [PMID: 17059514]
215. de Bie C, Kindermann A, Escher J. Use of exclusive enteral nutrition in paediatric Crohn's disease in The Netherlands. J Crohns Colitis 2013; 7: 263-270 [PMID: 22820027 DOI: 10.1016/ j.crohns.2012.07.001]
216. Jackson CA, Clatworthy J, Robinson A, Horne R. Factors associated with non-adherence to oral medication for inflammatory bowel disease: A systematic review. Am J Gastroenterol 2010; 105: 525-539 [PMID: 19997092 DOI: 10.1038/ajg.2009.685]
217. Mukai J, Miyanaga Y, Ishizaka T, Asaka K, Nakai Y, Tsuji E, Uchida T. Quantitative taste evaluation of total enteral nutrients. Chem Pharm Bull (Tokyo) 2004; 52: 1416-1421 [PMID: 15577236]
218. Miyanaga Y, Mukai J, Mukai T, Odomi M, Uchida T. Suppression of the bitterness of enteral nutrients using increased particle sizes of branched-chain amino acids (BCAAs) and various flavours: A taste sensor study. Chem Pharm Bull (Tokyo) 2004; 52: 490-493 [PMID: 15056975 DOI: 10.1248/cpb.52.490]
219. Takagi S, Utsunomiya K, Kuriyama S, Yokoyama H, Takahashi S, Umemura K, Iwabuchi M, Takahashi H, Takahashi S, Kinouchi Y, Hiwatashi N, Funayama Y, Sasaki I, Tsuji I, Shimosegawa T. Quality of life of patients and medical cost of "half elemental diet" as maintenance therapy for Crohn's disease: secondary outcomes of a randomised controlled trial. Dig Liver Dis 2009; 41: 390-394 [PMID: 18945653 DOI: 10.1016/j.dld.2008.09.007]
220. Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, Davies S, Murch S, Derkx B, Heuschkel R, Fell JM. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment Pharmacol Ther 2004; 20: 167-172 [PMID: 15233696]
221. Guo Z, Wu R, Zhu W, Gong J, Zhang W, Li Y, Gu L, Li N, Li J. Effect of exclusive enteral nutrition on health-related quality of life for adults with active Crohn's disease. Nutr Clin Pract 2013; 28: 499-505 [PMID: 23851180 DOI: 10.1177/0884533613487218]
222. Berni Canani R, Terrin G, Borrelli O, Romano MT, Manguso F, Coruzzo A, D'Armiento F, Romeo EF, Cucchiara S. Shortand long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease. Dig Liver Dis 2006; 38: 381-387 [PMID: 16301010]
223. Knight C, El-Matary W, Spray C, Sandhu BK. Long-term outcome of nutritional therapy in paediatric Crohn's disease. Clin Nutr 2005; 24: 775-779 [PMID: 15904998]
224. Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 2000; 31: 8-15 [PMID: 10896064]
225. Dziechciarz P, Horvath A, Shamir R, Szajewska H. Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther 2007; 26: 795-806 [PMID: 17767463]
226. Cameron FL, Gerasimidis K, Papangelou A, Missiou D, Garrick V, Cardigan T, Buchanan E, Barclay AR, McGrogan P, Russell RK. Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn's disease. Aliment Pharmacol Ther 2013; 37: 622-629 [PMID: 23360085 DOI: 10.1111/apt.12230]
227. Soo J, Malik BA, Turner JM, Persad R, Wine E, Siminoski K, Huynh HQ. Use of exclusive enteral nutrition is just as effective as corticosteroids in newly diagnosed pediatric Crohn's disease. Dig Dis Sci 2013; 58: 3584-3591 [PMID: 24026403 DOI: 10.1007/ s10620-013-2855-y]
228. Lambert B, Lemberg DA, Leach ST, Day AS. Longer-term outcomes of nutritional management of Crohn's disease in children. Dig Dis Sci 2012; 57: 2171-2177 [PMID: 22661250 DOI: 10.1007/s10620-012-2232-2]
229. Fiocchi C. Inflammatory bowel disease pathogenesis: where are we? J Gastroenterol Hepatol 2015; 30 Suppl 1: 12-18 [PMID: 25827798 DOI: 10.1111/jgh.12751]